Cumberland Pharmaceuticals (CPIX) Cash from Operations Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 81.06% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 8.26% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -46.22% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 63.59% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 73.78% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 33.73% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 16.88% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - | -560.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -560.36% |
| Mar 31, 2026 | -90.07% |
| Dec 31, 2025 | -99.84% |
| Sep 30, 2025 | -60.64% |
| Jun 30, 2025 | 198.61% |
| Mar 31, 2025 | 282.46% |
| Dec 31, 2024 | 83.12% |
| Sep 30, 2024 | -61.55% |
| Jun 30, 2024 | -116.34% |
| Mar 31, 2024 | -50.66% |
| Dec 31, 2023 | -71.41% |
| Sep 30, 2023 | -53.08% |
| Jun 30, 2023 | 124.64% |
| Mar 31, 2023 | -842.34% |
| Dec 31, 2022 | 5.43% |
| Sep 30, 2022 | 265.43% |
| Jun 30, 2022 | -13.66% |
| Mar 31, 2022 | -108.43% |
| Dec 31, 2021 | 304.10% |
| Sep 30, 2021 | -171.48% |